Tri Locum Partners LP’s Moonlake Immunotherapeutics Position
Does Tri Locum Partners LP own Moonlake Immunotherapeutics (MLTX)? Not currently — the last reported position was 47.6K shares worth $3M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q4 2023
Shares
47.6K
% of Portfolio
+1.31%
Quarters Held
2
position exited
Position History MLTX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tri Locum Partners LP’s full portfolio or all institutional holders of MLTX.